<html><head><link rel="stylesheet" type="text/css" href="css/style.css"></head><body><div id="main"><h1>Scignal</h1></div> <div class="container"><div class="row"><div class="search"><h2>All Results for :  "AAV" AND "immunogenicity"</a></h2></div><table><tr><td class="head"><h3>BioRxiv</h3></td><td class="head"><h3>PubMed</h3></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Rational design of a compact CRISPR-Cas9 activator for AAV- mediated delivery</h4><p><a href="https://www.biorxiv.org/content/10.1101/298620v1">Link</a></p><p><b>Date:</b> 2018-04-15</p><p><b>Authors:</b> Suhani Vora ... George Church</p><p><b>Downloads:</b> 3407</p><p><b>Relevance Score:</b> 0.71</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Akin to Zinc Finger and Transcription Activator Like Effector based transcriptional modulators, nuclease-null CRISPR-Cas9 provides a groundbreaking programmable DNA binding platform, begetting an arsenal of targetable regulators for transcriptional and epigenetic perturbation, by either directly tethering, or recruiting, transcription enhancing effectors to either component of the Cas9/guide RNA complex.  Application of these programmable regulators is now gaining traction for the modulation of disease-causing genes or activation of therapeutic genes, in vivo.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Durable multitransgene expression in vivo using systemic, nonviral DNA delivery.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31807699">Link</a></p><p><b>Date:</b> 2019-12-06</p><p><b>Authors:</b> Chakkrapong Handumrongkul ...  Robert Debs</p><p><b>Journal:</b> Sci Adv</p><p><b>IF (7 or above):</b> 12.53</p><p><b>Relevance Score:</b> 0.29</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Recombinant adeno-associated virus (AAV) vectors are transforming therapies for rare human monogenic deficiency diseases.  However, adaptive immune responses to AAV and its limited DNA insert capacity, restrict their therapeutic potential.</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Methods Matter -- Standard Production Platforms For Recombinant AAV Can Produce Chemically And Functionally Distinct Vectors</h4><p><a href="https://www.biorxiv.org/content/10.1101/640169v2">Link</a></p><p><b>Date:</b> 2019-05-17</p><p><b>Authors:</b> Neil G. Rumachik ... Nicole K. Paulk</p><p><b>Downloads:</b> 3795</p><p><b>Relevance Score:</b> 0.57</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Different manufacturing approaches have been used in the production of recombinant adeno-associated virus (rAAV).  We sought to characterize differences in rAAV vectors when produced by the two leading manufacturing platforms; live baculovirus infection of Sf9 insect cells and transiently-transfected human HEK293 cells.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32170079">Link</a></p><p><b>Date:</b> 2020-03-14</p><p><b>Authors:</b> Peter Gee ...  Akitsu Hotta</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.8</p><p><b>Relevance Score:</b> 0.29</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Prolonged expression of the CRISPR-Cas9 nuclease and gRNA from viral vectors may cause off-target mutagenesis and immunogenicity.  Thus, a transient delivery system is needed for therapeutic genome editing applications.</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Two-Step Small Scale Purification of Recombinant Adeno-Associated Viruses</h4><p><a href="https://www.biorxiv.org/content/10.1101/715029v1">Link</a></p><p><b>Date:</b> 2019-07-25</p><p><b>Authors:</b> Shih-Heng Chen ... Negin P. Martin</p><p><b>Downloads:</b> 410</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Recombinant adeno-associated viruses (AAVs) are robust and versatile tools for in vivo gene delivery.  Natural and designer capsid variations in AAVs allow for targeted gene delivery to specific cell types.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: A single combination gene therapy treats multiple age-related diseases.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31685628">Link</a></p><p><b>Date:</b> 2019-11-06</p><p><b>Authors:</b> Noah Davidsohn ...  George M Church</p><p><b>Journal:</b> Proc. Natl. Acad. Sci. U.S.A.</p><p><b>IF (7 or above):</b> 9.35</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Comorbidity is common as age increases, and currently prescribed treatments often ignore the interconnectedness of the involved age-related diseases.  The presence of any one such disease usually increases the risk of having others, and new approaches will be more effective at increasing an individu ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Targeting T cell malignancies using CAR-based immunotherapy: challenges and potential solutions.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31884955">Link</a></p><p><b>Date:</b> 2019-12-30</p><p><b>Authors:</b> Lauren C Fleischer ...  Sunil S Raikar</p><p><b>Journal:</b> J Hematol Oncol</p><p><b>IF (7 or above):</b> 8.71</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Chimeric antigen receptor (CAR) T cell therapy has been successful in treating B cell malignancies in clinical trials; however, fewer studies have evaluated CAR T cell therapy for the treatment of T cell malignancies.  There are many challenges in translating this therapy for T cell disease, includi ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31815633">Link</a></p><p><b>Date:</b> 2019-12-09</p><p><b>Authors:</b> Hongbo Wang ...  Xiangxuan Zhao</p><p><b>Journal:</b> J Hematol Oncol</p><p><b>IF (7 or above):</b> 8.71</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Hepatocellular carcinoma (HCC, also called primary liver cancer) is one of the most fatal cancers in the world.  Due to the insidiousness of the onset of HCC and the lack of effective treatment methods, the prognosis of HCC is extremely poor, and the 5-year average survival rate is less than 10%.</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: The role of hypoxia-inducible factors in neovascular age-related macular degeneration: a gene therapy perspective.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31893312">Link</a></p><p><b>Date:</b> 2020-01-01</p><p><b>Authors:</b> Parviz Mammadzada ...  Helder Andr√©</p><p><b>Journal:</b> Cell. Mol. Life Sci.</p><p><b>IF (7 or above):</b> 7.03</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Understanding the mechanisms that underlie age-related macular degeneration (AMD) has led to the identification of key molecules.  Hypoxia-inducible transcription factors (HIFs) have been associated with choroidal neovascularization and the progression of AMD into the neovascular clinical phenotype  ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32170083">Link</a></p><p><b>Date:</b> 2020-03-14</p><p><b>Authors:</b> Guan Wang ...  Si-Yi Chen</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.8</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Oncolytic viruses offer an in situ vaccination approach to activate tumor-specific T cell responses.  However, the upregulation of PD-L1 expression on tumor cells and immune cells leads to tumor resistance to oncolytic immunotherapy.</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Disruption of the HIV-1 Envelope allosteric network blocks CD4-induced rearrangements.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31980614">Link</a></p><p><b>Date:</b> 2020-01-25</p><p><b>Authors:</b> Rory Henderson ...  S Munir Alam</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.8</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The trimeric HIV-1 Envelope protein (Env) mediates viral-host cell fusion via a network of conformational transitions, with allosteric elements in each protomer orchestrating host receptor-induced exposure of the co-receptor binding site and fusion elements.  To understand the molecular details of t ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31836711">Link</a></p><p><b>Date:</b> 2019-12-14</p><p><b>Authors:</b> Nicholas D Weber ...  Cristian Smerdou</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.8</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Progressive familial intrahepatic cholestasis type 3 (PFIC3) is a rare monogenic disease caused by mutations in the ABCB4 gene, resulting in a reduction in biliary phosphatidylcholine.  Reduced biliary phosphatidylcholine cannot counteract the detergent effects of bile salts, leading to cholestasis, ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: CRISPR-Switch regulates sgRNA activity by Cre recombination for sequential editing of two loci.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31784531">Link</a></p><p><b>Date:</b> 2019-11-30</p><p><b>Authors:</b> Krzysztof Chylinski ...  Ulrich Elling</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.8</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> CRISPR-Cas9 is an efficient and versatile tool for genome engineering in many species.  However, inducible CRISPR-Cas9 editing systems that regulate Cas9 activity or sgRNA expression often suffer from significant limitations, including reduced editing capacity, off-target effects, or leaky expressio ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32019587">Link</a></p><p><b>Date:</b> 2020-02-05</p><p><b>Authors:</b> Pan Wu ...  Wei Xiong</p><p><b>Journal:</b> Mol. Cancer</p><p><b>IF (7 or above):</b> 11.35</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Non-coding RNAs do not encode proteins and regulate various oncological processes.  They are also important potential cancer diagnostic and prognostic biomarkers.</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Preclinical and Clinical Development of Noncoding RNA Therapeutics for Cardiovascular Disease.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32105576">Link</a></p><p><b>Date:</b> 2020-02-27</p><p><b>Authors:</b> Cheng-Kai Huang ...  Thomas Thum</p><p><b>Journal:</b> Circ. Res.</p><p><b>IF (7 or above):</b> 10.57</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> RNA modulation has become a promising therapeutic approach for the treatment of several types of disease.  The emerging field of noncoding RNA-based therapies has now come to the attention of cardiovascular research, in which it could provide valuable advancements in comparison to current pharmacoth ....</p></div></td></div></tr></table></div><hr></div></body></html>